Senseonics Holdings, Inc. (SENS) |
|
1.16 0 (0%)
|
11-25 13:00 |
|
Open: |
1.14 |
Pre. Close: |
1.16 |
|
High:
|
1.18 |
Low:
|
1.13 |
|
Volume:
|
972,280 |
Market Cap:
|
555(M) |
|
|
|
Technical analysis |
as of: 2022-11-25 2:00:17 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 1.51 One year: 1.77 |
| Support: |
Support1: 1.12 Support2: 1.01 |
| Resistance: |
Resistance1: 1.29 Resistance2: 1.51 |
| Pivot: |
1.18  |
| Moving Average: |
MA(5): 1.15 MA(20): 1.18
MA(100): 1.41 MA(250): 1.7 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 51.2 %D(3): 49.4 |
| RSI: |
RSI(14): 45.9 |
| 52-week: |
High: 3.89 Low: 0.76 |
| Average Vol(K): |
3-Month: 3,130 (K) 10-Days: 2,643 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SENS ] has closed above bottom band by 38.9%. Bollinger Bands are 53.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.17 - 1.18 |
1.18 - 1.18 |
|
Low:
|
1.09 - 1.09 |
1.09 - 1.1 |
|
Close:
|
1.15 - 1.16 |
1.16 - 1.17 |
|
Company Description |
|
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. |
Headline News |
Sat, 26 Nov 2022
Bennet aims to leverage lame duck session to revive expanded child tax credit - Lamar Ledger
Fri, 25 Nov 2022
Recap: Ducks Can't Slow Down Sens in 5-1 Black Friday Loss - NHL.com
Fri, 25 Nov 2022
Belleville Sens Make Two Roster Moves Ahead of Weekend Set with Laval - OurSports Central
Fri, 25 Nov 2022
Wilson: The Sens are having a hard time handling in-game shifts of momentum - TSN
Thu, 24 Nov 2022
Sens Ownership War, Trade Season Starts, NHL Fights Back and More - Silver Seven
Mon, 21 Nov 2022
Sens, Dokkaebi, and Osa speed and health values changed with Y7S4 Operation Solar Raid — SiegeGG - SiegeGG
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
446 (M) |
| Shares Float |
316 (M) |
|
% Held by Insiders
|
10.1 (%) |
|
% Held by Institutions
|
31.3 (%) |
|
Shares Short
|
75,530 (K) |
|
Shares Short P.Month
|
76,920 (K) |
Stock Financials |
|
EPS
|
-1.31 |
|
EPS Est Next Qtl
|
-0.16 |
|
EPS Est This Year
|
-0.55 |
|
EPS Est Next Year
|
-0.64 |
|
Book Value (p.s.)
|
-0.61 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-395.1 |
|
Return on Assets (ttm)
|
-25.4 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
360.5 |
|
Gross Profit (p.s.)
|
-0.04 |
|
Sales Per Share
|
0.03 |
|
EBITDA (p.s.)
|
-0.12 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-53 (M) |
|
Levered Free Cash Flow
|
-35 (M) |
Stock Valuations |
|
PE Ratio
|
-0.89 |
|
PEG Ratio
|
-0.2 |
|
Price to Book value
|
-1.94 |
|
Price to Sales
|
38.17 |
|
Price to Cash Flow
|
-9.86 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
